Investors pause after a frenetic week in a healthy reality check
US markets finished broadly flat in what could be termed as a healthy reality check.
Many sectors appear to have run ahead of themselves, such that the quantum of the tax reforms will need to be substantial and President Trump will need to be convincing in terms of his ability to deliver the promises in order to at least maintain the current bullish undertones.
While the Dow finished broadly in line with the previous day’s close, the NASDAQ came off nearly 0.2%.
Weakness in the oil price also contributed to a sharp early fall in US markets, and this was a factor in the FTSE 100 shedding 0.3% to close at 7277 points.
Interestingly, the downturn in the oil price in the morning session reversed in the latter part of trading, and it was as though this shaped the Dow’s movements as it fell from approximately 50 points in early trading before pushing up to close at 20,619 points, up eight points on the previous day’s close
However, European markets weren’t open when the reversal in the oil price occurred. Consequently, markets in mainland Europe were also lower with the DAX off 0.3% and the Paris CAC 40 shedding 0.5%
Mining stocks were also out of favour as base metals were mainly lower.
Copper, zinc and lead all lost ground with the latter coming off more than 2%.
However, nickel bucked the trend finally pushing up through the US$5.00 per pound level, representing a gain of approximately 1%.
Gold was well supported as it gained 0.6% to finish at US$1240 per ounce.
The Australian dollar weakened slightly to finish just below the US$0.77 mark.
With little direction coming from overseas it is likely to be ASX listed companies reporting their results that drives the market. Some of the bigger players reporting today include Santos, ASX and Medibank Private.
It will also be an interesting day in the retail space with Lovisa, The Reject Shop and Baby Bunting Group reporting their interim results.
It should be noted that broker projections and price targets are only estimates and may not be met. Also, historical data in terms of earnings performance and/or share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering this stock should seek independent financial advice.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.